• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
DNLI

DNLI

Denali Therapeutics Inc.

NASDAQHealthcareBiotechnologyUS

USD19.66

+0.31 (+1.60%)

Rating:C

Company Profile

CEO

Ryan J. Watts

IPO Date

2017-12-08

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$19.34

Prev. Close

$19.35

Day Low

$19.19

Day High

$19.69

52W Low

$12.58

52W High

$23.77

Market Cap

$3.12B

Volume

1.01M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Analyst Consensus
Buy

Strong Buy

0

Buy

18

Hold

0

Sell

0

Strong Sell

0

Analyst Grades
DateFirmPreviousNew GradeAction
26 May 2026Morgan StanleyOverweightOverweightmaintain
14 May 2026Morgan StanleyOverweightOverweightmaintain
11 May 2026BTIGBuyBuymaintain
8 May 2026
Wedbush
Outperform
Outperform
maintain
22 Apr 2026Leerink PartnersOutperformOutperformmaintain
7 Apr 2026BairdOutperformOutperformmaintain
26 Mar 2026Morgan StanleyOverweightOverweightmaintain
26 Mar 2026HC Wainwright & Co.BuyBuymaintain
26 Mar 2026Goldman SachsBuyBuymaintain
26 Mar 2026BairdOutperformOutperformmaintain